Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartphone mindfulness app tested to lower heart disease risk

NCT ID NCT06152185

First seen Feb 22, 2026 · Last updated Jun 23, 2026 · Updated 10 times

Summary

This study tests whether a smartphone-based mindfulness training program can reduce stress and improve cardiovascular health in stressed adults aged 45 and older who are at risk for heart disease. About 106 participants will either use the app for 28 days or continue their usual routine. Researchers will measure changes in stress, blood pressure, and daily life reactions over three months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mindfulness training app

What this could lead to

If it works, this could point toward a simple, low-cost way to lower stress and improve heart health in at-risk adults.

What could go wrong

This is a small, early feasibility study with only 106 participants. Results may not apply to everyone, and the app may not produce lasting changes in stress or blood pressure.

Conditions

The condition(s) this trial relates to.

cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.